The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
BeOne Medicines
Bayer
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Jazz Pharmaceuticals
AstraZeneca
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Genentech, Inc.
BioNTech SE
Brigham and Women's Hospital
Poseida Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
Daiichi Sankyo
Takeda
Cue Biopharma
Second Life Therapeutics
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Innate Pharma
Var2 Pharmaceuticals
GlaxoSmithKline
University of Pittsburgh
Tanabe Pharma America, Inc.
European Institute of Oncology
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Hospices Civils de Lyon
BicycleTx Limited
National Institutes of Health Clinical Center (CC)
Rondo Therapeutics
Actym Therapeutics, Inc.
Shanghai Escugen Biotechnology Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Washington University School of Medicine
3B Pharmaceuticals GmbH
Palleon Pharmaceuticals, Inc.
Exelixis
Incyte Corporation
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Cancer Research UK